the research, conducted at pennsylvania’s school of dental medicine and published in the journal molecular therapy , represents a low-cost way to limit the spread of a virus that has been slowed — but not stopped — by vaccination. previous studies have shown that people who are double dosed can still carry a viral load similar to the unvaccinated, making new tools a necessity in efforts to finally put the pandemic in the past.
“sars-cov-2 replicates in the salivary glands and we know that when someone who is infected sneezes, coughs or speaks, some of that virus can be expelled and reach others,” said henry daniell , lead researcher and vice chair in the department of basic and translational sciences at the school. “this gum offers an opportunity to neutralize the virus in the saliva, giving us a simple way to possibly cut down on a source of disease transmission.”
advertisement
advertisement
dave yasvinski is a writer with healthing.ca